Particle-induced osteolysis in three-dimensional micro-computed tomography.

Department of Orthopedics, University of Duisburg-Essen, Hufelandstr. 55, 45122 Essen, Germany.
Calcified Tissue International (Impact Factor: 2.75). 12/2007; 81(5):394-402. DOI: 10.1007/s00223-007-9077-2
Source: PubMed

ABSTRACT Small-animal models are useful for the in vivo study of particle-induced osteolysis, the most frequent cause of aseptic loosening after total joint replacement. Microstructural changes associated with particle-induced osteolysis have been extensively explored using two-dimensional (2D) techniques. However, relatively little is known regarding the 3D dynamic microstructure of particle-induced osteolysis. Therefore, we tested micro-computed tomography (micro-CT) as a novel tool for 3D analysis of wear debris-mediated osteolysis in a small-animal model of particle-induced osteolysis. The murine calvarial model based on polyethylene particles was utilized in 14 C57BL/J6 mice randomly divided into two groups. Group 1 received sham surgery, and group 2 was treated with polyethylene particles. We performed 3D micro-CT analysis and histological assessment. Various bone morphometric parameters were assessed. Regression was used to examine the relation between the results achieved by the two methods. Micro-CT analysis provides a fully automated means to quantify bone destruction in a mouse model of particle-induced osteolysis. This method revealed that the osteolytic lesions in calvaria in the experimental group were affected irregularly compared to the rather even distribution of osteolysis in the control group. This is an observation which would have been missed if histomorphometric analysis only had been performed, leading to false assessment of the actual situation. These irregularities seen by micro-CT analysis provide new insight into individual bone changes which might otherwise be overlooked by histological analysis and can be used as baseline information on which future studies can be designed.


Available from: Carl Neuerburg, May 04, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Problems in metal-on-metal (MoM) hip replacement systems still persist due to high wear rates, low corrosion resistance and release of toxic ions and nanoparticles. As a consequence of these effects, failure, infections, loosening or bone resorption is the typical problems in the hip prosthesis. In order to reduce failure due to corrosion and/or releasing ions and particles, this study presents some works in a novel nanoscale surface modification of cobalt-chromium alloy (CoCr) for obtaining improved surface conditions in these alloys for these applications. Improving corrosion resistant of these alloys and achieving a low wear rate are possible to reduce the total released ions and particles released from the surface of this material. According to it, three different treatments using oxygen at temperatures of 300°C, 350°C and 400°C were carried out by plasma immersion ion implantation technique (PI3). X-ray diffraction (XRD) analysis shows an increase in the formation of chromium oxides in the outer surface of the CoCr alloy. It allows improving in corrosion resistant in CoCr alloys. Moreover, total quantity of released Co, Cr and Mo ions have been reduced. Wear rate studies showed a very similar behaviour after the treatments in relation to untreated CoCr alloy and release rate from the treated surface of CoCr alloys was reduced in comparison with untreated CoCr alloy.
    Journal of Biomaterials and Nanobiotechnology 03/2015; DOI:10.4236/jbnb.2015.62009
  • [Show abstract] [Hide abstract]
    ABSTRACT: Titanium (Ti) particle-induced periprosthetic osteolysis and subsequent aseptic loosening are a primary reason for total hip arthroplasty failure. The aim of this study was to assess the effect of myricetin on Ti particle-induced osteolysis and osteoclastogenesis. We demonstrated that myricetin, a natural plant extract, exerts potent inhibitory effects on Ti particle-induced osteolysis in a mouse calvarial model. Further histological analysis indicated that the inhibition of osteoclast formation and function, and the secretion of inflammatory factors, are key targets for therapeutic agents in the treatment of wear particle-induced osteolysis. In vitro, we found that myricetin suppressed receptor activator of nuclear factor-κB ligand (RANKL)-mediated osteoclast differentiation, bone resorption, and F-actin ring formation in a dose-dependent manner. Moreover, myricetin significantly reduced the expression of osteoclast-specific markers in mouse bone marrow-derived macrophages, including tartrate-resistant acid phosphatase (TRAP), cathepsin K, the calcitonin receptor, V-ATPase d2, c-fos, and nuclear factor of activated T cells (NFAT) c1. Further investigation revealed that myricetin inhibited osteoclastogenesis through the suppression of the nuclear factor-κB (NF-κB) signaling pathway and mitogen-activated protein kinase (MAPK) pathways involving extracellular signal-regulated kinase 1/2 (ERK1/2), p38, and c-Jun N-terminal kinase 1/2 (JNK1/2). While, the inhibition of TNF-α and IL-1β secretion was another reason for the suppressive effect of myricetin on Ti particle-induced osteolysis. Collectively, these findings suggest that myricetin is a potential natural agent for the treatment of periprosthetic osteolysis and other osteoclast-related osteolytic diseases.
    Biochemical Pharmacology 11/2014; DOI:10.1016/j.bcp.2014.10.019 · 4.65 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Detection of peptides from the calcitonin (CT) family in the periarticular tissue of loosened implants has raised hopes to open new regenerative therapies in the process of aseptic loosening which remains the major cause of early implant failure in endoprosthetic surgery. We have shown previously the roles of α-Calcitonin gene-related peptide (α-CGRP) and the CALCA gene which encodes α-CGRP/CT in this process. To uncover the role of direct CTR (Calcitonin receptor) mediated signalling, we studied particle induced osteolysis (PIO) in a murine calvaria model with a global deletion of the CTR (CTR-KO) using μCT analysis and histomorphometry. As expected, CTR-KO mice revealed reduced bone volume compared to wild type (WT) controls (p<0.05). In CTR-KO mice we found significantly higher RANKL (Receptor Activator of NF-κB Ligand) expression in the particle group than in the control group. The increase in osteoclast numbers by the particles was twice as high as the increase of osteoclasts in the WT mice (400% vs 200%). Changes in eroded surface and actual osteolysis due to UHMWPE (Ultra-high molecular weight polyethylene) -particles were similar in WTs and CTR-KOs. Taken together, our findings strengthen the relevance of the OPG/RANK/RANKL system in the process of PIO. CTR seems to have an effect on osteoclast differentiation in this context. As there were no obvious changes of the amount of PIO in CTR deficiency, regenerative strategies in aseptic loosening of endoprosthetic implants based on peptides arising from the CT-family should rather focus on the impact of α-CGRP. Copyright © 2014. Published by Elsevier Ltd.
    Acta Biomaterialia 12/2014; 14. DOI:10.1016/j.actbio.2014.11.051 · 5.68 Impact Factor